✦ LIBER ✦

Postoperative Melagatran/ Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery

✍ Scribed by Dr Ola E. Dahl, Bengt I. Eriksson, Giancarlo Agnelli, Alexander T. Cohen, Patrick Mouret, Nadia Rosencher, Seva Panfilov, Anders Bylock, Magnus Andersson

Book ID: 119929975
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 162 KB
Volume: 25
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200525010-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ximelagatran approved in France for prev

Ximelagatran approved in France for prevention of venous thromboembolic events in major orthopaedic surgery

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Ximelagatran, a new oral direct thrombin

Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations

✍ N. Rosencher 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Meta-analysis of trials comparing ximela

Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery

✍ A. T. Cohen; C. Hirst; B. Sherrill; P. Holmes; D. Fidan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 3 views

Prevention of venous thromboembolism aft

Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?

✍ Gordon DO Lowe; Peter AG Sandercock; Frits R Rosendaal 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 53 KB

Fondaparinux Compared with Enoxaparin fo

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

✍ Bauer, Kenneth A.; Eriksson, Bengt I.; Lassen, Michael R.; Turpie, Alexander G.G 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 102 KB

PCV114 DABIGATRAN ETEXILATE IS COST-SAVI

PCV114 DABIGATRAN ETEXILATE IS COST-SAVING FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS FOLLOWING MAJOR ORTHOPAEDIC SURGERY IN THE NETHERLANDS

✍ C Boersma; BS Kappelhoff; MJ Postma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB